Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation

Diabetes manifests as chronic inflammation and leads to the development diabetic cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new therapy for DCM. In this study, the authors explore the pharmacological effects and mechanisms of Schisandrin B (Sch B), a natural c...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wu, Lin, Ke, Hua, Junyi, Han, Jibo, Zhang, Qiuyan, Chen, Lingfeng, Khan, Zia A., Wu, Gaojun, Wang, Yi, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631063/
https://www.ncbi.nlm.nih.gov/pubmed/36180407
http://dx.doi.org/10.1002/advs.202202590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631063/
https://www.ncbi.nlm.nih.gov/pubmed/36180407
http://dx.doi.org/10.1002/advs.202202590

Ejemplares similares